
News & Insights

Antibody-Dependent Enhancement Risk for SARS-CoV-2 Vaccine Developers
This article explores a phenomenon called Antibody-Dependent Enhancement (ADE). This occurs when binding of a virus to non-neutralizing antibodies enhances its entry into host cells, and sometimes also its replication. The clinical outcome in individuals where an immune response results in the production…

New Policy for SARS–CoV–2 Serology Tests
FDA significantly tightened oversight on SARS‐COV‐2 serology tests by publishing new policy requiring all serology tests to be reviewed and approved under Emergency Use Authorization (EUA). In a rush to make serology antibody tests available as quickly as possible, FDA previously allowed SARSCOV‐ 2…